Contact Us   |   Sign In   |   Join CAHR
CMAP Program
Share |

Become a CAHR/CCPE Certified Market Access Professional

CAHR is very excited to offer our professional Certification program for our members, developed by a team of respected and experienced leaders in the field of market access in concert with the Council for Continuing Pharmaceutical Education (CCPE). CCPE is the accreditation body for Innovative Medicines Canada's member company employees (Code of Ethical Practices CCPE works to ensure that our certification program delivers credible, meaningful proof of your commitment to enhancing your professional abilities.


The CAHR Certification program allows you to be recognized for the unique skill set that defines the role of the modern market access professional. Our program is comprehensive and complete, encompassing a broad range of subjects of direct relevance to your daily activities.


Successful completion of the program qualifies you as a Certified Market Access Professional. Your academic achievement will be verifiable through either CCPE or CAHR.



Certification Requirements

The program combines the independent learning process of CCPE’s module-based approach with CAHR’s educational conferences.

  • The CCPE Pharmaceutical Market Access in Canada course provides a comprehensive guide to the factors affecting the market access environment in Canada. The course includes a 200-page binder of information, which will require approximately 20 hours of study to complete.*
  • The CAHR Market Access 101 (MA101) Conference provides an introduction to the various fields of activity involved in market access, from clinical trials to budget impact analysis and government relations.
  • The CAHR Market Access 201 (MA201) Conference expands upon the Market Access 101 course information and takes its ideas further, providing context and insight to better understand the issues facing market access professionals.

Participants can sign up at any time and can start with the CCPE courseware, which can be completed from the comfort of your home. The CCPE materials include an authoritative guide to every aspect of the market access and reimbursement environment, with online testing at your convenience. Attendance at CAHR’s MA101 and MA201 is required to complete the course, but no testing will be conducted on the material covered at these conferences.


* Note that if you have completed this course through CCPE within the last 3 years, you will receive credit and will only need to attend the MA101 and MA201 conferences in order to achieve your Certification.


Certification Objectives: Upon completion of the CMAP Program, you will be able to:

  • Explain why market access is critical to commercial success
  • Describe the market access players in the public and private payer environments
  • Discuss how review processes, pricing and regulations impact public and private payer environments
  • Find the information necessary to understand the various public and private submission processes
  • Identify key players in the market access and reimbursement environment
  • Discuss the intricacies of bringing a new drug to market in Canada
  • Identify the key approvals pathways, processes and agencies involved in bringing a new drug to market in Canada

Certification Program Costs: The costs of the certification program are as follows.

CCPE course component:

 $    569  (a 50% discount from the CCPE non-member cost)

Market Access 101 in person event admission:   
 $    860
Market Access 201 in person event admission: 
 $    860
 $ 2,289



The Certification program is only open to CAHR members.* To learn more about becoming a member and the many benefits of doing so, please visit our Membership page.

  • Calendar

Completed all credits required? Click here to apply for your CMAP Certificate.


Membership Software Powered by YourMembership  ::  Legal